跳至主要内容
临床试验/NL-OMON24635
NL-OMON24635尚未招募不适用

Pentoxifylline dose optimization in preterm neonatal sepsis

Erasmus Medical Center0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Neonates with gestational age <30 weeks
  • - suspected of late onset sepsis with blood drawn for blood culture and
  • inflammatory biomarkers
  • - IL-6 >500 pg/mL or CRP >50 mg/L at onset

排除标准

  • - PTX therapy cannot be started within 24 hours of start of antibiotic treatment.
  • - Patients with major congenital defects (e.g. congenital heart disease,
  • pulmonary, or gastrointestinal anomalies) will also be excluded.
  • - If subjects have IL-6 values exceeding 25000 pg/mL at time of onset they will also be excluded. High IL-6 values represent severe episodes of sepsis and high IL-6 values are associated with high mortality rates.
  • - Patients who already participated in this trial during an earlier episode of late onset sepsis.
  • - pH below 7 in two consecutive blood samples, with at least 1 hour between the blood samples, at onset of sepsis

研究者

相似试验